02315 Stock: Price, Forecast, Financials & AI Analysis

High

Open

VWAP

Vol

Mkt Cap

Low

Amount

EV/EBITDA(TTM)

Total Shares

EV/OCF(TTM)

P/S(TTM)

0 Analyst Rating

Wall Street analysts forecast 02315 stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for 02315 is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

0 Buy

0 Hold

0 Sell

Current: 0.000

Low

Averages

High

Current: 0.000

Low

Averages

High

No data

Valuation Metrics

The current forward P/E ratio for BIOCYTOGEN-B (02315.HK) is 72.21, compared to its 5-year average forward P/E of -15.24. For a more detailed relative valuation and DCF analysis to assess BIOCYTOGEN-B 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A

5Y Average PE

-15.24

Current PE

72.21

Overvalued PE

8.46

Undervalued PE

-38.95

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A

5Y Average EV/EBITDA

-25.95

Current EV/EBITDA

56.15

Overvalued EV/EBITDA

70.48

Undervalued EV/EBITDA

-122.37

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

N/A

5Y Average PS

4.46

Current PS

13.65

Overvalued PS

9.69

Undervalued PS

-0.76

Financials

Annual

Quarterly

Trading Trends

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Hedge Fund

Hedge Funds are Neutral. There are no significant trading trends over the last quarter.

Sold

Bought

Congress Trading

Congress are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

02315 News & Events

Events Timeline

No data

News

4.5

2025-12-24aastocks

HSI Rises 44 Points in Half-Day Trading as SMIC Jumps Over 3% and BIOCYTOGEN-B Surges 20%

2.0

2025-12-24aastocks

BIOCYTOGEN-B Surges Over 20% Following Inclusion in Southbound Stock Connect

2.0

2025-12-24aastocks

BIOCYTOGEN-B Now Included in Securities Eligible for Southbound Stock Connect, Effective Immediately

People Also Watch

Frequently Asked Questions

What is BIOCYTOGEN-B (02315) stock price today?

The current price of 02315 is 35.9 USD — it has increased 2.69 % in the last trading day.

What is BIOCYTOGEN-B (02315)'s business?

What is the price predicton of 02315 Stock?

Wall Street analysts forecast 02315 stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for 02315 is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is BIOCYTOGEN-B (02315)'s revenue for the last quarter?

BIOCYTOGEN-B revenue for the last quarter amounts to NaN USD, decreased % YoY.

What is BIOCYTOGEN-B (02315)'s earnings per share (EPS) for the last quarter?

BIOCYTOGEN-B. EPS for the last quarter amounts to USD, decreased % YoY.

What changes have occurred in the market's expectations for BIOCYTOGEN-B (02315)'s fundamentals?

The market is revising No Change the revenue expectations for 02315 for , with the revenue forecasts being adjusted by % over the past three months. During the same period, the stock price has changed by %.

How many employees does BIOCYTOGEN-B (02315). have?

BIOCYTOGEN-B (02315) has 0 emplpoyees as of January 09 2026.

What is BIOCYTOGEN-B (02315) market cap?

Today 02315 has the market capitalization of 0.00 USD.